Kiora Pharmaceuticals Inc (KPRX) Price Prediction & ForecastKPRXKiora Pharmaceuticals Inc

Alphio's KPRX stock price prediction model matches the current Kiora Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.41 (-0.06%). The 1-week path is $1.41 (-0.17%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Kiora Pharmaceuticals Inc is not a good buy right now. The stock is currently priced at $1.41, which is significantly below its 52-week high of $2.91, indicating a substantial decline. The RSI is at a very low 19.17, suggesting that the stock is oversold, but this could also indicate persistent weakness. Additionally, the forward P/E ratio is 2.41, which might seem attractive, but the company has reported consistent losses, including a Q1 loss of $0.58 per share and a net income of -$2,417,984 for Q1 2026. The main risk is the high volatility and lack of profitability, as evidenced by a 20-day change of -44.49%.

Kiora Pharmaceuticals Inc (KPRX) last closed at $1.41, losing -6.00%. These facts feed the 1-day and 1-week KPRX price prediction above.